[Antitumor properties of 2-phenazinylthioureidotyrosine].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010619:Phenazines / Q000627:therapeutic use*; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy*; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010619:Phenazines; D014443:Tyrosine; C011976:2-phenazinylthioureidotyrosine
Protipukhlinni vlastivosti 2-fenaziniltioureidotirozinu